BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7161850)

  • 1. Bioactivation of halogenated hydrocarbons.
    Anders MW
    J Toxicol Clin Toxicol; 1982 Aug; 19(6-7):699-706. PubMed ID: 7161850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1.
    Raucy JL; Kraner JC; Lasker JM
    Crit Rev Toxicol; 1993; 23(1):1-20. PubMed ID: 8471158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of halogenated solvents.
    Anders MW; Jakobson I
    Scand J Work Environ Health; 1985; 11 Suppl 1():23-32. PubMed ID: 3906866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial bioactivation of cysteine S-conjugates and 4-thiaalkanoates: implications for mitochondrial dysfunction and mitochondrial diseases.
    Anders MW
    Biochim Biophys Acta; 1995 May; 1271(1):51-7. PubMed ID: 7599225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of toxic glutathione conjugates from halogenated alkenes.
    Dekant W
    Toxicol Lett; 2003 Sep; 144(1):49-54. PubMed ID: 12919723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-dependent bioactivation of haloalkenes.
    Anders MW; Dekant W
    Annu Rev Pharmacol Toxicol; 1998; 38():501-37. PubMed ID: 9597164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation of xenobiotics by formation of toxic glutathione conjugates.
    Koob M; Dekant W
    Chem Biol Interact; 1991; 77(2):107-36. PubMed ID: 1991332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate beta-lyase.
    Dekant W; Vamvakas S; Anders MW
    Drug Metab Rev; 1989; 20(1):43-83. PubMed ID: 2653763
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro comparative bioactivation of aliphatic halogenated hydrocarbons.
    Sipes IG; Gandolfi AJ
    Dev Toxicol Environ Sci; 1980; 8():501-6. PubMed ID: 7308050
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of dihaloalkanes by thiol-dependent mechanisms.
    Guengerich FP
    J Biochem Mol Biol; 2003 Jan; 36(1):20-7. PubMed ID: 12542971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reductive metabolism of halogenated alkanes by liver microsomal cytochrome P450.
    Nastainczyk W; Ahr HJ; Ullrich V
    Biochem Pharmacol; 1982 Feb; 31(3):391-6. PubMed ID: 7073766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halogenated methanes: metabolism and toxicity.
    Ahmed AE; Kubic VL; Stevens JL; Anders MW
    Fed Proc; 1980 Nov; 39(13):3150-5. PubMed ID: 6775982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereo- and regioselective conjugation of S-halovinyl mercapturic acid sulfoxides by glutathione S-transferases.
    Rosner E; Müller M; Dekant W
    Chem Res Toxicol; 1998 Jan; 11(1):12-8. PubMed ID: 9477221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereochemical aspects of the glutathione S-transferase-catalyzed conjugations of alkyl halides.
    Ridgewell RE; Abdel-Monem MM
    Drug Metab Dispos; 1987; 15(1):82-90. PubMed ID: 2881763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characteristics of compounds that can be activated to chemically reactive metabolites: use for a prediction of a carcinogenic potential.
    Lutz WK
    Arch Toxicol Suppl; 1984; 7():194-207. PubMed ID: 6595983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P-450 mediated genetic activity and cytotoxicity of seven halogenated aliphatic hydrocarbons in Saccharomyces cerevisiae.
    Callen DF; Wolf CR; Philpot RM
    Mutat Res; 1980 Jan; 77(1):55-63. PubMed ID: 6767185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of the nephrotoxic haloalkene 1,1,2-trichloro-3,3,3-trifluoro-1-propene by glutathione conjugation.
    Vamvakas S; Kremling E; Dekant W
    Biochem Pharmacol; 1989 Jul; 38(14):2297-304. PubMed ID: 2751695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination reactions in the medium-chain acyl-CoA dehydrogenase: bioactivation of cytotoxic 4-thiaalkanoic acids.
    Baker-Malcolm JF; Haeffner-Gormley L; Wang L; Anders MW; Thorpe C
    Biochemistry; 1998 Feb; 37(5):1383-93. PubMed ID: 9477967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.
    Ahr HJ; King LJ; Nastainczyk W; Ullrich V
    Biochem Pharmacol; 1982 Feb; 31(3):383-90. PubMed ID: 7073765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac.
    Boerma JS; Vermeulen NP; Commandeur JN
    Chem Biol Interact; 2014 Jan; 207():32-40. PubMed ID: 24246759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.